Search Results 331-340 of 4560 for 留痕官网咨询邮箱：lgooxc@hotmail.com

  1. Lung Transplant - Contact us - Mayo Clinic

    Mayo Clinic transplant staff are committed to helping you understand the transplant process at Mayo Clinic before, during and after your surgery.

  2. Services and contact - Center for Clinical and Translational Science

    The Office of Digital Innovation: Offers project consultations in clinical informatics and digital approach. Conducts structured interviews to understand grant ...

  3. Study to Evaluate the Efficacy and Safety of CUDC-907 in Patients With RR DLBCL, Including Patients With MYC Alterations - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  4. Phase 2 Study with TTI-622 and TTI-621 in Relapsed Diffuse Large B-Cell Lymphoma (DLBCL) - Mayo Clinic

    About this study. The purpose of ths study is to find out more about the side effects of two new drug combinations for lymphoma, TTI-621 and pembrolizumab ...

  5. Contact - Human Immunodeficiency Virus Lab: Andrew D. Badley - Mayo Clinic Research

    Contact information for Dr. Badley's Human Immunodeficiency Virus Laboratory at Mayo Clinic's campus in Minnesota.

  6. VX15/2503 in Combination With Avelumab in Advanced Non-small Cell Lung Cancer - Mayo Clinic

    The purpose of this study is to evaluate the safety and tolerability of IV administration of VX15/2503 in combination with a fixed dose of avelumab in patients ...

  7. Mayo Clinic

    ... . VID-20259565. Home; BrightCove - A New Life The Journey of Vivian Tsai at Mayo Clinic. Fuel groundbreaking medical research!

  8. Detection of Vascular and Inflammatory Plasma Biomarkers in Patients Diagnosed with Obstructive Sleep Apnea and MRI-defined Cerebral Small Vessel Disease - Mayo Clinic

    The purpose of this study is to evaluate plasma biomarkers of vascular function and inflammation in patients with newly-diagnosed Obstructive Sleep Apnea (OSA) ...

  9. Midostaurin Access Program for Newly Diagnosed FLT3 (ITD or TKD) Mutated AML Adult Patients Eligible for Standard Induction and Consolidation Chemotherapy - Mayo Clinic

    Midostaurin Access Program for Newly Diagnosed FLT3 (ITD or TKD) Mutated AML Adult Patients Eligible for Standard Induction and Consolidation Chemotherapy.

  10. A Study to Evaluate the Safety and Tolerability of DCC-2618 in Patients with Advanced Malignancies - Mayo Clinic

    This is a Phase 1, open-label, first-in-human (FIH) dose-escalation study designed to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics ...